“…DBIBB was effective in mitigating HEM-ARS in the TBI model when administration began up to 72 h postirradiation. There are few reports in the literature on radioprotective and radiomitigative compounds (Anzai, et al, 2013; Basile, et al, 2012; Berbee, et al, 2011; Burdelya, et al, 2008; Gaberman, et al, 2013; Gao, et al, 2012; Geiger, et al, 2012; Haydont, et al, 2007; Kim, et al, 2013; Saha, et al, 2011; Sridharan, et al, 2013; Wang, et al, 2013), however, most of these interventions lose efficacy when administered 24 h postinjury or they are efficacious only in treating single-organ injury. The effective protection we detected with delayed administration of DBIBB indicates that the initial tissue damage sustained during the first 72 postirradiation hours can be effectively treated.…”